Furthermore, variants in genes such as PNPLA3 and WNT9A have been linked to increased HCC susceptibility, whereas polymorphisms in HSD17B13 are associated with a reduced risk for HCC and improved patient survival outcomes.81 Here, WNT9A is linked to hepatocellular carcinoma.